J&J, Bayer, Eli Lilly, Amgen, Onyx, AstraZeneca, Pfizer, Amplimmune and Novartis

– Johnson & Johnson, which two years ago said it was looking at adding warnings to Tylenol bottle caps, is now doing that. FiercePharma’s J&J Follows Up on Pledge To Add Warning To Tylenol Bottle Caps outlines the consumer communications development from McNeil Consumer Healthcare

– CoreBrand included more than 500 companies in its annual survey of brand respect, the 100 best-known brands being ranked according to their “favorability.” The best-known and most popular of these are then named the “most respected corporate brands”. PharmaLive’s BrandPower Ranking: Bayer Among The Most Respected Brands In The U.S.  reveals that among pharmaceutical and chemical companies, Bayer was ranked first

– Humana Inc and Eli Lilly and Company announced a joint research collaboration aimed at improving the health care of their members and patients. Humana and Lilly Form Research Collaboration To Improve Health Care Outcomes explains under the partnership, the companies will utilize their expertise and resources to identify and analyze data and information with a focus on improving health care quality and outcomes

– Amgen’s purchase of Onyx Pharmaceuticals for the sake of cancer drugs prompted much discussion in the pharmaceutical world, but AstraZeneca was also buying medicine in that category. AstraZeneca To Acquire Amplimmune, A Biologics Company Focusing On Cancer Drugs  reports MedCity News. Amplimmune, a privately held biologics company, focuses on developing drugs in cancer immunology

– Pfizer has remained the world’s largest public manufacturer of pharmaceuticals, according to an industry report, though dropped revenue in 2012 has left Novartis hot on its heels. In-PharmaTechnologist.com’s Novartis Sneaking Up On Pfizer For Pharma’s Top Spot  highlights the results from IndustryWeek 1000’s recent public manufacturers report